APLP1 and Alzheimer disease: Interestingly, in AD patients secreted fragments of APLP1 arising due to β-secretase (BACE) processing have recently been identified as a sensitive cerebrospinal fluid biomarker (Dislich et al., 2015; Simoes et al., 2020).